Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis
Authors:
Open Access
- 26 December 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 192 (1) , 7-17
Abstract
Summary: A new procedure was developed and applied to study immunoglobulin free light chains (FLC) in saliva of healthy subjects and patients with multiple sclerosis (MS). The procedure was based on a Western blot analysis for detection and semiquantitative evaluation of monomeric and dimeric FLCs. The FLC indices accounting for the total FLC levels and for the monomer/dimer ratios of κ and λ FLC were calculated, and the cut-off values of the FLC indices were determined to distinguish healthy state from MS disease. The obtained FLC index values were statistically different in the saliva of three groups: active MS patients, MS patients in remission and healthy subjects groups. Our FLC monomer–dimer analysis allowed differentiation between healthy state and active MS with specificity of 100% and a sensitivity of 88·5%. The developed technique may serve as a new non-invasive complementary tool to evaluate the disease state by differentiating active MS from remission with sensitivity of 89% and specificity of 80%.Keywords
Funding Information
- National Multiple Sclerosis Society (PP-1512–07139)
This publication has 28 references indexed in Scilit:
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with ProgressionPLOS ONE, 2013
- Secretory immunity with special reference to the oral cavityJournal of Oral Microbiology, 2013
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Free light chain monomers in the diagnosis of multiple sclerosisJournal of Neuroimmunology, 2010
- Free light chains in plasma of patients with light chain amyloidosis and non‐amyloid light chain deposition disease. High proportion and heterogeneity of disulfide‐linked monoclonal free light chains as pathogenic features of amyloid diseaseBritish Journal of Haematology, 2009
- Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseasesTrends in Pharmacological Sciences, 2008
- Kappa Free Light Chains in Cerebrospinal Fluid as Markers of Intrathecal Immunoglobulin SynthesisClinical Chemistry, 2004
- Color reaction between pyrogallol red-molybdenum(VI) complex and protein.BUNSEKI KAGAKU, 1983
- J Chain in Malignant Human IgG ImmunocytesScandinavian Journal of Immunology, 1975
- A SUBCLASS OF HUMAN γA-GLOBULINS (γA2) WHICH LACKS THE DISULFIDE BONDS LINKING HEAVY AND LIGHT CHAINSJournal of Experimental Medicine, 1968